| New pharmacological strategies for the treatment of non-infectious uveitis. a minireview RA Valenzuela, I Flores, B Urrutia, F Fuentes, PE Sabat, C Llanos, ... Frontiers in Pharmacology 11, 655, 2020 | 34 | 2020 |
| Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions C Falcón-Beas, A Tittarelli, G Mora-Bau, F Tempio, C Pérez, D Hevia, ... Immunobiology 224 (5), 697-705, 2019 | 27 | 2019 |
| Evaluation of the immune response induced by CoronaVac 28-day schedule vaccination in a healthy population group A Escobar, FE Reyes-López, ML Acevedo, L Alonso-Palomares, ... Frontiers in immunology 12, 766278, 2022 | 19 | 2022 |
| Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response A Pérez-Baños, MA Gleisner, I Flores, C Pereda, M Navarrete, JP Araya, ... British Journal of Cancer 129 (4), 572-585, 2023 | 17 | 2023 |
| Dendritic Cells Loaded with Heat Shock‐Conditioned Ovarian Epithelial Carcinoma Cell Lysates Elicit T Cell‐Dependent Antitumor Immune Responses In Vitro I Flores, D Hevia, A Tittarelli, D Soto, D Rojas-Sepúlveda, C Pereda, ... Journal of immunology research 2019 (1), 9631515, 2019 | 14 | 2019 |
| Definition of uveitis refractory to treatment: a systematic review in the absence of a consensus RA Valenzuela, I Flores, M Pujol, C Llanos, E Carreño, G Rada, ... Ocular immunology and inflammation 30 (1), 174-179, 2022 | 9 | 2022 |
| Co-expression of immunohistochemical markers MRP2, CXCR4, and PD-L1 in gallbladder tumors is associated with prolonged patient survival A Tittarelli, O Barría, E Sanders, A Bergqvist, DU Brange, M Vidal, ... Cancers 15 (13), 3440, 2023 | 2 | 2023 |
| Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy A Tittarelli, C Pereda, MA Gleisner, MN López, I Flores, F Tempio, ... Vaccines 12 (4), 357, 2024 | | 2024 |
| Co-Expression of Immunohistochemical Markers MRP2, CXCR4, and PD-L1 in Gallbladder Tumors Is Associated with Prolonged Patient Survival. Cancers 2023, 15, 3440 A Tittarelli, O Barría, E Sanders, A Bergqvist, DU Brange, M Vidal, ... | | 2023 |
| Dendritic cells in cancer immunotherapy: Transducers of CD4+ T cell cooperation towards an effective antitumor response C Fuentes, I Flores, C Falcon, F Salazar-Onfray, M Lopez EUROPEAN JOURNAL OF IMMUNOLOGY 48, 167-167, 2018 | | 2018 |
| Ovarian carcinoma cell line lysates are a potent maturation stimulus and tumoral antigen source for therapeutic dendritic cell enablement against cancer I Flores, F Tempio, C Fuentes, C Perez, I Pepper, C Pereda, ... EUROPEAN JOURNAL OF IMMUNOLOGY 48, 166-166, 2018 | | 2018 |
| Characterization of antigenic tumor lysates for ex vivo activation of dendritic cells against ovarian cancer I Flores | | 2018 |
